GlassScriptPhysician profile
Cheryl L Jeter
NPI 1801078696
$5,666.93
in general payments reported to CMS, 2019-2025
38 companies · $1,230 in 2025
The $1,230 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,239 · 2022: $1,043 · 2023: $1,187 · 2024: $968 · 2025: $1,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,385.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,685.24 | 2021-2025 | |
| Pfizer INC. | $710.08 | 2021-2025 | |
| Lundbeck LLC | $704.93 | 2021-2025 | Vyepti |
| Lilly USA, LLC | $222.14 | 2021-2024 | Emgality, Reyvow |
| Amgen INC. | $200.88 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $159.75 | 2024-2025 | |
| Allergan, INC. | $157.24 | 2021 | |
| Globus Medical, INC. | $133.34 | 2024-2025 | Si-Lok, Xlif, Tlif |
| Biohaven Pharmaceuticals, INC. | $128.12 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $120.30 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $119.97 | 2021-2022 | |
| Merz Pharmaceuticals, LLC | $104.44 | 2023-2024 | Xeomin |
| Abbott Laboratories | $97.62 | 2021-2025 | Proclaim |
| Almatica Pharma LLC | $87.14 | 2021-2023 | Gralise |
| Collegium Pharmaceutical, INC. | $83.39 | 2022-2024 | Xtampza |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Jeter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.